SLAMF1 and Burkitt lymphoma: Indeed, Takeda et al. (2014) observed SLAMF1/CD150 expression in BL-41, BJAB, and Mutu EBV-positive Burkitt lymphoma cells bearing type III latency but not in EBV-negative or type I latency BL41, Akata, BJAB, Daudi, or Mutu Burkitt lymphoma cells [41].